Zhaorui Medical (Shenzhen) Co., LTD

Zhaorui Medical (Shenzhen) Co., Ltd. specializes in centrifugal sample concentrators, which are designed to process biological samples efficiently. Their most common product, the Automatic High-throughput Exosome Extractor, is intended for laboratory use to isolate and concentrate exosomes from fluids like blood or urine. These devices automate the concentration process, improving workflow in research and diagnostic settings.

Zhaorui Medical (Shenzhen) Co., Ltd. is based in the United States. While the company’s location influences its regulatory obligations—such as compliance with U.S. FDA requirements—it does not inherently determine whether its devices are authorized. Instead, individual devices undergo their own regulatory evaluation to determine compliance with applicable standards, such as FDA classification rules.

Zhaorui Medical’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This inclusion is important because the UDI system ensures traceability and transparency in the medical device supply chain, helping regulators, healthcare providers, and patients verify device identity, recall status, and compliance with regulatory requirements.

Zhaorui Medical’s devices, including the Automatic High-throughput Exosome Extractor, are classified as FDA Class I. This classification generally means the devices pose minimal risk to users and typically require less stringent premarket review, such as 510(k) clearance or de novo pathways, unless they involve new or novel technologies. Class I devices often undergo general controls to ensure safety and effectiveness.